Evidence map›Paper›PMID 39192310›Full record

ArticleArchives of public health = Archives belges de sante publique2024

Policy brief of the Belgian Europe's Beating Cancer Plan mirror group: children, adolescents and young adults with cancer.

Hélène A Poirel, Gabrielle Schittecatte, Fabienne Van Aelst, on behalf of the Thematic Working Group (TWG) ‘Children, Adolescents and Young Adults (CAYAs) with Cancer’

Abstract read
In one paragraph

Article in Archives of public health = Archives belges de sante publique, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Policy brief - cancer research in Belgium.Archives of public health = Archives belges de sante publique · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hélène A PoirelSciensano, Cancer Centre, Sciensano, Brussels, Belgium. Helene.Antoine-Poirel@sciensano.be.ORCID http://orcid.org/0000-0002-0712-5127
Gabrielle SchittecatteSciensano, Cancer Centre, Sciensano, Brussels, Belgium.
Fabienne Van AelstSciensano, Cancer Centre, Sciensano, Brussels, Belgium.
on behalf of the Thematic Working Group (TWG) ‘Children, Adolescents and Young Adults (CAYAs) with Cancer’

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Children and Adolescents and Young Adults with cancer represent a young population with specific needs, which need to be addressed in a patient- and cancer-driven way. There is an urgent need to support and extend the ongoing initiatives in Belgium. First, multidisciplinary care programmes dedicated to children need to be reviewed, and those for Adolescents and Young Adults need to be developed with close collaboration between paediatric and adult oncology and haematology teams. This needs to be done considering the entire patient journey; from cancer prevention, diagnosis, treatment, rehabilitation, follow-up of late effects, transition pathways between paediatric and adult wards, and palliative care. Second, national haemato/oncology precision programmes adapted to this young population with rare cancers, including infrastructure to manage cancer gene predisposition in CAYAs with cancers and their relatives, needs to be developed. This multi-level plan aims to ensure improved outcome with high quality of care for the young population with cancer in Belgium in line with Europe's Beating Cancer Plan initiatives.

Indexed as

Adolescents and Young Adults (AYA) with cancerChildhood cancerEurope’s Beating Cancer Plan (EBCP)Policy BriefPolicy Recommendations

Identifiers

PMID39192310
PMCPMC11348532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.